NCT01319916View on ClinicalTrials.gov

Lipid and Adipokine Profiles Following Subcutaneous Injection of ATX-101 Into Abdominal Fat Tissue

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Healthy
Interventions
DRUG

ATX-101

ATX-101 2mg/cm2

Trial Locations (1)

58104

Robert Cooper, M.D. Cetero Research, Fargo

Sponsors
All Listed Sponsors
lead

Kythera Biopharmaceuticals

INDUSTRY

NCT01319916 - Lipid and Adipokine Profiles Following Subcutaneous Injection of ATX-101 Into Abdominal Fat Tissue | Biotech Hunter | Biotech Hunter